NCT00828646View on ClinicalTrials.gov

Safety Study of Multiple-dose of Gamma-secretase Inhibitor in Healthy Male Japanese and Healthy Elderly Japanese

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Healthy
Interventions
DRUG

BMS-708163

Capsules, Oral, 50 mg, once daily, 14 days

DRUG

BMS-708163

Capsules, Oral, 100 mg/day, once daily, 14 days

DRUG

BMS-708163

Capsules, Oral, 75 or 100 mg/day, once daily, 14 days

DRUG

Placebo

Capsules, Oral, once daily, 14 days

Trial Locations (1)

2320064

Local Institution, Yokohama

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT00828646 - Safety Study of Multiple-dose of Gamma-secretase Inhibitor in Healthy Male Japanese and Healthy Elderly Japanese | Biotech Hunter | Biotech Hunter